Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
Joint Bone Spine
; 88(6): 105226, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1243034
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Musculoskeletal Diseases
/
Antirheumatic Agents
/
COVID-19 Drug Treatment
Type of study:
Experimental Studies
Limits:
Humans
Language:
English
Journal:
Joint Bone Spine
Journal subject:
Rheumatology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS